Yahoo Web Search

Search results

    • News Analysis - Nature Reviews Drug Discovery

      Nature· 4 days ago

      The US and European regulatory authorities have asked Pfizer to withdraw its selective cyclooxygenase 2 (COX2) inhibitor, valdecoxib (Bextra), from the market. Is this a sign that the FDA is ...